318 related articles for article (PubMed ID: 32945066)
1. Changes in fecal short-chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome.
El-Salhy M; Valeur J; Hausken T; Gunnar Hatlebakk J
Neurogastroenterol Motil; 2021 Feb; 33(2):e13983. PubMed ID: 32945066
[TBL] [Abstract][Full Text] [Related]
2. Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome.
El-Salhy M; Casen C; Valeur J; Hausken T; Hatlebakk JG
World J Gastroenterol; 2021 May; 27(18):2219-2237. PubMed ID: 34025075
[TBL] [Abstract][Full Text] [Related]
3. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
[No Abstract] [Full Text] [Related]
4. Long-term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome.
El-Salhy M; Kristoffersen AB; Valeur J; Casen C; Hatlebakk JG; Gilja OH; Hausken T
Neurogastroenterol Motil; 2022 Jan; 34(1):e14200. PubMed ID: 34145677
[TBL] [Abstract][Full Text] [Related]
5. The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors.
Lin H; Guo Q; Wen Z; Tan S; Chen J; Lin L; Chen P; He J; Wen J; Chen Y
Microb Cell Fact; 2021 Dec; 20(1):233. PubMed ID: 34963452
[TBL] [Abstract][Full Text] [Related]
6. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation.
Mazzawi T; Lied GA; Sangnes DA; El-Salhy M; Hov JR; Gilja OH; Hatlebakk JG; Hausken T
PLoS One; 2018; 13(11):e0194904. PubMed ID: 30427836
[TBL] [Abstract][Full Text] [Related]
7. The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms.
El-Salhy M; Mazzawi T; Hausken T; Hatlebakk JG
Scand J Gastroenterol; 2022 Sep; 57(9):1036-1045. PubMed ID: 35486073
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study.
El-Salhy M; Hatlebakk JG; Gilja OH; Bråthen Kristoffersen A; Hausken T
Gut; 2020 May; 69(5):859-867. PubMed ID: 31852769
[TBL] [Abstract][Full Text] [Related]
9. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study.
Halkjær SI; Christensen AH; Lo BZS; Browne PD; Günther S; Hansen LH; Petersen AM
Gut; 2018 Dec; 67(12):2107-2115. PubMed ID: 29980607
[TBL] [Abstract][Full Text] [Related]
10. Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21
El-Salhy M; Patcharatrakul T; Gonlachanvit S
World J Gastroenterol; 2021 Jun; 27(22):2921-2943. PubMed ID: 34168399
[TBL] [Abstract][Full Text] [Related]
11. Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota.
Huang HL; Chen HT; Luo QL; Xu HM; He J; Li YQ; Zhou YL; Yao F; Nie YQ; Zhou YJ
J Dig Dis; 2019 Aug; 20(8):401-408. PubMed ID: 31070838
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
Mazzawi T; El-Salhy M; Lied GA; Hausken T
Front Cell Infect Microbiol; 2021; 11():524851. PubMed ID: 34055657
[TBL] [Abstract][Full Text] [Related]
13. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
Holvoet T; Joossens M; Vázquez-Castellanos JF; Christiaens E; Heyerick L; Boelens J; Verhasselt B; van Vlierberghe H; De Vos M; Raes J; De Looze D
Gastroenterology; 2021 Jan; 160(1):145-157.e8. PubMed ID: 32681922
[TBL] [Abstract][Full Text] [Related]
14. Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation.
El-Salhy M; Mazzawi T; Hausken T; Hatlebakk JG
Neurogastroenterol Motil; 2022 Sep; 34(9):e14353. PubMed ID: 35302268
[TBL] [Abstract][Full Text] [Related]
15. Changes in colonic enteroendocrine cells of patients with irritable bowel syndrome following fecal microbiota transplantation.
Mazzawi T; Hausken T; El-Salhy M
Scand J Gastroenterol; 2022 Jul; 57(7):792-796. PubMed ID: 35156893
[TBL] [Abstract][Full Text] [Related]
16. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial.
Aroniadis OC; Brandt LJ; Oneto C; Feuerstadt P; Sherman A; Wolkoff AW; Kassam Z; Sadovsky RG; Elliott RJ; Budree S; Kim M; Keller MJ
Lancet Gastroenterol Hepatol; 2019 Sep; 4(9):675-685. PubMed ID: 31326345
[TBL] [Abstract][Full Text] [Related]
17. Fecal microbiota transplantation in patients with irritable bowel syndrome: an overview of current studies.
Körner E; Lorentz A
J Appl Microbiol; 2023 Mar; 134(3):. PubMed ID: 36882216
[TBL] [Abstract][Full Text] [Related]
18. Engraftment of strictly anaerobic oxygen-sensitive bacteria in irritable bowel syndrome patients following fecal microbiota transplantation does not improve symptoms.
Browne PD; Cold F; Petersen AM; Halkjær SI; Christensen AH; Günther S; Hestbjerg Hansen L
Gut Microbes; 2021; 13(1):1-16. PubMed ID: 34074214
[TBL] [Abstract][Full Text] [Related]
19. Fecal microbiota transplantation in irritable bowel syndrome: A systematic review and meta-analysis.
Myneedu K; Deoker A; Schmulson MJ; Bashashati M
United European Gastroenterol J; 2019 Oct; 7(8):1033-1041. PubMed ID: 31662860
[TBL] [Abstract][Full Text] [Related]
20. Fecal Fermentation in Irritable Bowel Syndrome: Influence of Dietary Restriction of Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols.
Valeur J; Røseth AG; Knudsen T; Malmstrøm GH; Fiennes JT; Midtvedt T; Berstad A
Digestion; 2016; 94(1):50-6. PubMed ID: 27487397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
